Code:
DRPS0038A
Active Ingredient:
Pantoprazole Na Sesquihydrate 40mg
Description:
Yellow oval enteric coated tablet embossed "HL" on one side and "40" on other side.
Regulatory Class:
P1S1S3
Prescription Drug
HK-61594
Code:
DRPS0038A
Active Ingredient:
Pantoprazole Na Sesquihydrate 40mg
Description:
Yellow oval enteric coated tablet embossed "HL" on one side and "40" on other side.
Regulatory Class:
P1S1S3
Prescription Drug
HK-61594
Tab: Treatment of mild GERD & associated symptoms. Long-term management & prevention of relapse in reflux oesophagitis. Prevention of gastroduodenal ulcers induced by nonselective NSAIDs in patients at risk w/ a need for continuous NSAID treatment. Eradication of H. pylori. Duodenal ulcer, gastric ulcer & reflux esophagitis. Zollinger-Ellison syndrome & other pathological hypersecretory conditions.
Tab Treatment of mild GERD & associated symptoms 1 tab (20 mg)/day. Long-term management & prevention of relapse in reflux oesophagitis 1 tab (20 mg)/day, increased to 40 mg/day if a relapse occurs. Prevention of gastroduodenal ulcers induced by nonselective NSAIDs in patients at risk w/ a need for continuous NSAID treatment 1 tab (20 mg)/day. Eradication of H. pylori 1 tab (40 mg) bd w/ combination of amoxicillin 1,000 mg bd & clarithromycin 500 mg bd or metronidazole 500 mg bd & clarithromycin 500 mg bd or amoxicillin 1,000 mg bd & metronidazole 500 mg bd. Duodenal ulcer, gastric ulcer & reflux esophagitis 1 tab (40 mg) daily for 4 wk, may be increased to 2 tab daily. Zollinger-Ellison syndrome & other pathological hypersecretory conditions Initially 80 mg daily & should be adapted according to clinical needs.
Should be taken on an empty stomach: Take 1 hr before meals. Swallow whole, do not chew/crush.